Learn About Herpes Zoster Oticus

What is the definition of Herpes Zoster Oticus?
Herpes zoster oticus is a common complication of shingles, an infection caused by the varicella-zoster virus (which is the virus that also causes chickenpox). Shingles occurs in people who have had chickenpox and in whom the varicella-zoster virus becomes active again. Herpes zoster oticus is caused by the spread of the virus to facial nerves and can cause intense ear pain; a rash around the ear, mouth, face, neck, and scalp; and paralysis of the face. Other symptoms may include hearing loss, vertigo (feeling that the room is spinning), tinnitus (hearing abnormal sounds), nausea, vomiting, loss of taste in the tongue, and dry mouth and eyes.
Save information for later
Sign Up
What are the alternative names for Herpes Zoster Oticus?
  • Herpes zoster oticus
  • Facial nerve palsy due to VZV
  • Facial nerve palsy due to herpes zoster infection
  • Facial nerve paralysis due to VZV
  • Geniculate neuralgia
  • Hunt syndrome (formerly)
  • Hunt's syndrome (formerly)
  • Nervus intermedius neuralgia
  • Ramsay Hunt syndrome
  • Ramsay Hunt syndrome type 2 (formerly)
Who are the top Herpes Zoster Oticus Local Doctors?
AE
Dr. Alberto J. Espay
Neurology
Elite
Highly rated in
62
conditions
Neurology

UC Health

University Of Cincinnati Gardner Neuroscience Institute

3113 Bellevue Ave, 
Cincinnati, OH 

Alberto Espay is a Neurologist in Cincinnati, Ohio. Espay has been practicing medicine for over 29 years and is rated as an Elite expert by MediFind in the treatment of Herpes Zoster Oticus. He is also highly rated in 62 other conditions, according to our data. His top areas of expertise are Parkinson's Disease, Drug Induced Dyskinesia, Focal Dystonia, Torticollis, and Deep Brain Stimulation. Espay is currently accepting new patients.

BB
Bastiaan R. Bloem
Elite
Highly rated in
18
conditions

Dpt. Of Physiology, Radboud University Medical Center

Nijmegen, NL 

Bastiaan Bloem practices in Nijmegen, Netherlands. Bloem is rated as an Elite expert by MediFind in the treatment of Herpes Zoster Oticus. They are also highly rated in 18 other conditions, according to our data. Their top areas of expertise are Parkinson's Disease, Herpes Zoster Oticus, Drug Induced Dyskinesia, Deep Brain Stimulation, and Sacral Nerve Stimulation.

 
 
 
 
Learn about our expert tiers
Learn more
CL
Chin-hsien A. Lin
Elite
Highly rated in
9
conditions

National Taiwan University Hospital

Taipei, TW 

Chin-hsien Lin practices in Taipei, Taiwan. Lin is rated as an Elite expert by MediFind in the treatment of Herpes Zoster Oticus. They are also highly rated in 9 other conditions, according to our data. Their top areas of expertise are Herpes Zoster Oticus, Parkinson's Disease, Hallervorden-Spatz Disease, Drug Induced Dyskinesia, and Deep Brain Stimulation.

View All Doctors
What are the latest Herpes Zoster Oticus Clinical Trials?
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122/DNL151 in Participants With Parkinson's Disease and Pathogenic LRRK2 Variants
Enrollment Status: Recruiting
Publish Date: December 15, 2022
Intervention Type: Drug
Study Phase: Phase 3

Summary: In this study, researchers will learn more about a study drug called BIIB122 in participants with early-stage Parkinson's disease (PD). The study will focus on participants with a specific genetic variant in their LRRK2 gene. The main question researchers are trying to answer is if taking BIIB122 slows the worsening of PD more than placebo in the early stages of PD. To help answer this question, r...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants With Parkinson's Disease
Enrollment Status: Recruiting
Publish Date: December 15, 2022
Intervention Type: Drug
Study Phase: Phase 2

Summary: In this study, researchers will learn more about a study drug called BIIB122 in participants with early-stage Parkinson's disease (PD). In this study: Participants will take 225 milligrams (mg) of BIIB122 or a placebo as tablets by mouth. A placebo looks like the study drug but has no real medicine in it. Participants will take BIIB122 or placebo 1 time a day for up to a minimum of 48 weeks and a ...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 12, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Herpes Zoster Oticus?
Benefits of High-Dose Corticosteroid and Antiviral Agent Combination Therapy in the Treatment of House-Brackman Grade VI Ramsay Hunt Syndrome.
Condition: House-Brackman Grade VI Ramsay Hunt Syndrome
Journal: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
Treatment Used: High-Dose Corticosteroid and Antiviral Agent Combination Therapy
Number of Patients: 128
Published: July 25, 2022
Intratympanic corticosteroid for Bell's palsy and Ramsay Hunt syndrome: Systematic review and meta-analysis.
Condition: Bell's Palsy and Ramsay Hunt Syndrome
Journal: Auris, nasus, larynx
Treatment Used: Intratympanic Steroid Therapy (ITST)
Number of Patients: 350
Published: January 04, 2022
Tired of the same old research?
Check Latest Advances
Acute Parkinsonism in a Patient with Spinal Cord Injury: A Case Report.
Condition: Acute Parkinsonism in Patient with Spinal Cord Injury (SCI)
Journal: Journal of neurological surgery. Part A, Central European neurosurgery
Treatment Used: L-DOPA/Benserazide
Number of Patients: 1
Published: November 17, 2021
View All Latest Advances